Category: Becker’s ASC Review

Independence drives ASCs' cardiology revolution

Cardiology has emerged as a leading specialty in the ASC industry, particularly as increasingly complex procedures migrate to the outpatient setting. 

6 physician, payer conflicts in the last year

From gold card programs to reimbursement cuts, physicians across several specialties have clashed with payers over 2024 due to major policy changes. 

7 ASC closures in 2024: State-by-state breakdown

Here is a state-by-state breakdown of seven ASC closures Becker’s reported on in 2024:

Boston physician settles improper prescription allegations 

A family medicine physician in Three Rivers, Mass., will pay $220,000 to settle allegations he prescribed controlled substances outside the usual course of professional practice.

A rocky month for anesthesia reimbursement policy 

December has been a tumultuous month for anesthesia pay policy, as provider and public outrage has spurred two payers to reverse controversial reimbursement policies. 

A rocky month for anesthesia reimbursement policy 

December has been a tumultuous month for anesthesia pay policy, as provider and public outrage has spurred two payers to reverse controversial reimbursement policies. 

Arizona clinic owners plead guilty to healthcare fraud

Two Arizona residents have pleaded guilty to defrauding the Arizona Health Care Cost Containment System, Arizona’s Medicaid agency, through their behavioral health clinic. 

16 cardiology practices to pay $17.7M+ for false claims allegations 

Sixteen separate cardiology practices across 12 states have agreed to pay a total of more than $17.7 million to resolve allegations they overbilled Medicare for diagnostic radiopharmaceuticals. 

Spending bill leaves 2.83% physician pay cut in place

On Dec. 21, President Joe Biden signed a spending bill to keep the federal government operating into 2025, leaving the planned 2.83% across-the-board Medicare physician payment cut untouched. 

Where healthcare private equity legislation has fallen short

California and Massachusetts both attempted to pass legislation that would tighten regulations around private equity transactions in healthcare, but it is unlikely that either state will see the proposed bills become law before the end of 2024, Bloombe…